Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection

Pharmacology

Volumn 60, Issue 1, 2000, Pages 51-56

  Schatz, Dieter S ^b   Saria, Alois ^a  

^a Neurochemistry Unit   (Austria)

^b NONE

Author keywords

9 hydroxyrisperidone; Coulometric detection; Electrochemical detection; High performance liquid chromatography; Paroxetine; Risperidone

Indexed keywords

AMITRIPTYLINE; CHLORPROMAZINE; CHLORPROTHIXENE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; DIAZEPAM; DIBENZEPIN; DRUG METABOLITE; HALOPERIDOL; IMIPRAMINE; MIANSERIN; NORTRIPTYLINE; OXAZEPAM; PALIPERIDONE; PAROXETINE; REMOXIPRIDE; RISPERIDONE; THIORIDAZINE;

ACCURACY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; COULOMETRY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; TECHNIQUE;

EID: 0033985501     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028347     Document Type: Article

References (22)

1. Johnson AM: Paroxetine: A pharmacological review. Int Clin Psychopharmacol 1992;6:15-24.
2. Boyer WF, Feighner JP: An overview of paroxetine. J Clin Psychiatry 1992;53:3-6.
3. Petersen N, Bechgaard E, Sortwell RJ, Wetterberg L: Potent depletion of 5HT from monkey whole blood by a new 5HT uptake inhibitor, paroxetine (FG 7051). Eur J Pharmacol 1978; 52:115-119.
4. Eap CB, Bouchoux G, Amey M, Cochard N, Savary L, Baumann P: Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J Chromatogr Sci 1998;36:365-371.
5. Gupta RN: Column liquid chromatographic determination of paroxetine in human serum using solid-phase extraction. J Chromatogr [B] 1994;661:362-365.
6. Brett MA, Dierdorf HD, Zussman BD, Coates PE: Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;419:438-444.
7. Shin JG, Kim KA, Yoon YR, Cha IJ, Kim YH, Shin SG: Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma. J Chromatogr [B] 1998; 713:452-456.
8. Knoeller J, Vogt Schenkel R, Brett MA: A simple and robust HPLC method for the determination of paroxetine in human plasma. J Pharm Biomed Anal 1995;13:635-638.
9. Foglia JP, Sorisio D, Kirshner M, Pollock BG: Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection. J Chromatogr [B] 1997;693:147-151.
10. Härtter S, Hermes B, Szegedi A, Hiemke C: Automated determination of paroxetine and its main metabolite by column switching and online high-performance liquid chromatography. Ther Drug Monit 1994;16:400-406.
11. Janssen PA, Niemegeers CJE, Awouters F, Schellekens KH, Megens AAHP, Meert TF: Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 1988;244:685-693.
12. Lcysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA: Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 1988;247:661-670.
13. Roose K, Gelders Y, Heylen S: Risperidone (R64 766) in psychotic patients: A first clinical therapeutic exploration. Acta Psychiatr Belg 1988;88:233-241.
14. Meuldermans W, Monbaliu J, Hendrickx J, Lavrijsen K, Mannens G, van Beijsterveldt L, Woestenborghs R, Heykants J: Abstracts of Beltox Meeting, Louvain, Belgium, March 31, 1990.
15. Megens AAHP, Niemegeers CJE: Janssen Preclinical Research Report R 64766/23, Janssen, Beerse, June 1990.
16. Woestenborghs R, Geucns I, Van Roosbroeck D, Cornelissen L, Van Rompaey F, Knaeps F, Heykants J: Janssen Preclinical Research Report R 64766/24, Janssen, Beerse, August 1990.
17. Woestenborghs R, Lorreyne W, Van Rompay F, Heykants J: Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography. J Chromatogr 1992;583:223-230.
18. Olcsen OV, Linnet K: Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyris-peridonc in serum from patients comedicated with other psychotropic drugs. J Chromatogr [B] 1997;698:209-216.
19. Price MC, Hoffman DW: Therapeutic drug monitoring of risperidone and 9-hydroxyris-peridone in serum with solid-phase extraction and high-performance liquid chromatography. Ther Drug Monit 1997;19:333-337.
20. Le Moing JP, Edouard S, Levron JC: Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr Biomed Appl 1993; 614:333-339.
21. Aravagiri M, Marder SR, Van Putten T, Midha KK: Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: Application to therapeutic drug monitoring in schizophrenic patients. J Pharm Sci 1993;82:447-449.
22. Hariharan M, Kindt EK, VanNoord T, Tandon R: An improved sensitive assay for simultaneous determination of plasma haloperidol and reduced haloperidol levels by liquid chromatography using a coulometric detector. Ther Drug Monit 1989;11:701-707.